| 0ee34d78-d33f-4ec1-a67e-2715d9874788 | Oograma nas fezes | 40303268 | 1 | 2024-07-31T16:08:48.748032+00:00 | 2024-07-31T16:08:48.748032+00:00 |
| 6bc4bfb9-a009-42e9-9673-3ec6a80b1c0b | Resíduos alimentares, identificação, fezes | 40303276 | 1 | 2024-07-31T16:08:48.748414+00:00 | 2024-07-31T16:08:48.748414+00:00 |
| cd3f54e6-8066-469a-bc68-ba5b6ffa9bf4 | Elastase pancreática fecal | 40303284 | 1 | 2024-07-31T16:08:48.748830+00:00 | 2024-07-31T16:08:48.748830+00:00 |
| 5d8050d9-e3b2-4092-8854-5e5e029025ad | Fibrinopeptídeo A, antígeno | 40303292 | 1 | 2024-07-31T16:08:48.749251+00:00 | 2024-07-31T16:08:48.749251+00:00 |
| ae753126-708f-47dd-a235-22960e8fe4cb | Hemoglobina A2, cromatografia | 40303306 | 1 | 2024-07-31T16:08:48.749636+00:00 | 2024-07-31T16:08:48.749636+00:00 |
| f991a1b8-7331-4591-b81e-536bc84559b1 | Hemoglobina cromatografia | 40303314 | 1 | 2024-07-31T16:08:48.750026+00:00 | 2024-07-31T16:08:48.750026+00:00 |
| ace3b2cd-7d4d-49ed-9ded-8af0fd3d8cf3 | Fator IX, dosagem | 40304167 | 1 | 2024-07-31T16:08:48.757210+00:00 | 2024-07-31T16:08:48.757210+00:00 |
| 48dd55c8-220a-4530-8e06-965fbecc6c11 | Fator V, dosagem | 40304175 | 1 | 2024-07-31T16:08:48.757609+00:00 | 2024-07-31T16:08:48.757609+00:00 |
| ecba8d55-f2fa-42fc-b816-a62f9f05cd6a | Plástica do ducto parotídeo | 30202140 | 1 | 2024-07-31T16:08:46.121147+00:00 | 2024-07-31T16:08:46.121147+00:00 |
| c7bfbb66-5545-42b6-b885-9c3d860c54b7 | Fator VIII, dosagem | 40304183 | 1 | 2024-07-31T16:08:48.757993+00:00 | 2024-07-31T16:08:48.757993+00:00 |
| d84cf8ee-295c-4a61-b703-d91e1128fef4 | Fator VIII, dosagem do antígeno (Von Willebrand) | 40304191 | 1 | 2024-07-31T16:08:48.758380+00:00 | 2024-07-31T16:08:48.758380+00:00 |
| 98108a56-e956-4ab7-97b4-445c5a018960 | Fator VIII, dosagem do inibidor | 40304205 | 1 | 2024-07-31T16:08:48.759189+00:00 | 2024-07-31T16:08:48.759189+00:00 |
| 97d400e7-38f3-4f61-9a60-a11f8403032b | Fator X, dosagem | 40304213 | 1 | 2024-07-31T16:08:48.760000+00:00 | 2024-07-31T16:08:48.760000+00:00 |
| 145f1b9f-275b-42e1-abda-6f248b65bcad | Fator XI, dosagem | 40304221 | 1 | 2024-07-31T16:08:48.760577+00:00 | 2024-07-31T16:08:48.760577+00:00 |
| f56514a9-17c1-416d-a04f-ff89addf87cd | Fator XII, dosagem | 40304230 | 1 | 2024-07-31T16:08:48.761172+00:00 | 2024-07-31T16:08:48.761172+00:00 |
| 64a6ad87-e809-4731-a117-450d0c210993 | Fator XIII, pesquisa | 40304248 | 1 | 2024-07-31T16:08:48.761752+00:00 | 2024-07-31T16:08:48.761752+00:00 |
| 21893903-2505-49b9-8fd6-250993fa7d2c | Fenotipagem do sistema Rh-Hr (anti Rho(D) + anti Rh(C) + anti Rh(E) | 40304256 | 1 | 2024-07-31T16:08:48.762336+00:00 | 2024-07-31T16:08:48.762336+00:00 |
| 881e2332-0d57-4d58-ac24-eb43aefdcbd3 | Fibrinogênio, teste funcional, dosagem | 40304264 | 1 | 2024-07-31T16:08:48.762924+00:00 | 2024-07-31T16:08:48.762924+00:00 |
| 2d1b1a46-261e-45b4-ab88-94970defb373 | Filária, pesquisa | 40304272 | 1 | 2024-07-31T16:08:48.763516+00:00 | 2024-07-31T16:08:48.763516+00:00 |
| 286d0356-e54a-4022-b646-442d3d8baf2a | Grupo sanguíneo ABO, e fator Rho (inclui Du) - determinação | 40304299 | 1 | 2024-07-31T16:08:48.764665+00:00 | 2024-07-31T16:08:48.764665+00:00 |
| d33fce7c-048a-4f5b-abcf-cb85a288a7f8 | Ham, teste de (hemólise ácida) | 40304302 | 1 | 2024-07-31T16:08:48.765300+00:00 | 2024-07-31T16:08:48.765300+00:00 |
| ddfd1279-3f6f-4c23-bbe3-d61f07ba1679 | Heinz, corpúsculos, pesquisa | 40304310 | 1 | 2024-07-31T16:08:48.765892+00:00 | 2024-07-31T16:08:48.765892+00:00 |
| 5064b8e5-c50c-4d77-bb33-7b39a0ef3477 | Hemácias fetais, pesquisa | 40304329 | 1 | 2024-07-31T16:08:48.766437+00:00 | 2024-07-31T16:08:48.766437+00:00 |
| 35e94380-0c49-4be7-8273-a98b840a450b | Hematócrito, determinação do | 40304337 | 1 | 2024-07-31T16:08:48.767041+00:00 | 2024-07-31T16:08:48.767041+00:00 |
| 24672680-6420-4ca9-a078-ba7a3aeefa20 | Hemoglobina, dosagem | 40304345 | 1 | 2024-07-31T16:08:48.767635+00:00 | 2024-07-31T16:08:48.767635+00:00 |
| 47b36dc8-43b1-4a8e-997c-33cfcfdcb326 | Hemoglobina (eletroforese) - pesquisa e/ou dosagem | 40304353 | 1 | 2024-07-31T16:08:48.768224+00:00 | 2024-07-31T16:08:48.768224+00:00 |
| 06c0eb98-d4a2-41ce-9b62-4a410f13c8b7 | Hemograma com contagem de plaquetas ou frações (eritrograma, leucograma, plaquetas) | 40304361 | 1 | 2024-07-31T16:08:48.768797+00:00 | 2024-07-31T16:08:48.768797+00:00 |
| 4780d5e7-a5dd-42f4-8ebc-b3767450bf05 | Hemossedimentação, (VHS) - pesquisa e/ou dosagem | 40304370 | 1 | 2024-07-31T16:08:48.769366+00:00 | 2024-07-31T16:08:48.769366+00:00 |
| 8e38f7e9-8617-44dc-bd66-d0d70de3b952 | Retração do coágulo - pesquisa | 40304566 | 1 | 2024-07-31T16:08:48.785152+00:00 | 2024-07-31T16:08:48.785152+00:00 |
| f5f05b63-2f61-437b-a827-de96c3d3ae3c | Ristocetina, co-fator, teste funcional, dosagem | 40304574 | 1 | 2024-07-31T16:08:48.786002+00:00 | 2024-07-31T16:08:48.786002+00:00 |
| 816f86fb-3c12-4a3e-965f-e8fb0c2a5c56 | Tempo de coagulação - determinação | 40304582 | 1 | 2024-07-31T16:08:48.786743+00:00 | 2024-07-31T16:08:48.786743+00:00 |
| cdc77fa2-03d7-4b3a-9609-4244727fae7a | Laserterapia para o tratamento da mucosite oral / orofaringe, por sessão | 30202159 | 1 | 2024-07-31T16:08:46.122865+00:00 | 2024-07-31T16:08:46.122865+00:00 |
| 32a04b98-21ec-47e6-8c97-73de4bf2c4ec | Tempo de protrombina - determinação | 40304590 | 1 | 2024-07-31T16:08:48.787496+00:00 | 2024-07-31T16:08:48.787496+00:00 |
| a7ab8e32-8dff-461d-9cd2-9b47015d84be | Tempo de reptilase - determinação | 40304604 | 1 | 2024-07-31T16:08:48.788757+00:00 | 2024-07-31T16:08:48.788757+00:00 |
| ce9317c9-8e76-4874-9898-4057f4b7865c | Tempo de sangramento de IVY - deteminação | 40304612 | 1 | 2024-07-31T16:08:48.789939+00:00 | 2024-07-31T16:08:48.789939+00:00 |
| 8d749731-f244-442e-8a72-50d7e6464245 | Tempo de trombina - determinação | 40304620 | 1 | 2024-07-31T16:08:48.791140+00:00 | 2024-07-31T16:08:48.791140+00:00 |
| 1c0e9bf1-f609-42af-bfc5-729e447ab1c7 | Tripanossoma, pesquisa | 40304647 | 1 | 2024-07-31T16:08:48.793231+00:00 | 2024-07-31T16:08:48.793231+00:00 |
| 85f0b4c6-1743-4859-bbf5-767636114c17 | Tromboelastograma - pesquisa e/ou dosagem | 40304655 | 1 | 2024-07-31T16:08:48.794551+00:00 | 2024-07-31T16:08:48.794551+00:00 |
| 5401edd0-4832-451d-8678-334ace46da8d | Alfa-2antiplasmina, teste funcional | 40304663 | 1 | 2024-07-31T16:08:48.795454+00:00 | 2024-07-31T16:08:48.795454+00:00 |
| 76396176-93d0-4cbe-9acf-666208543fea | Anticorpo antimieloperoxidase, MPO - pesquisa e/ou dosagem | 40304671 | 1 | 2024-07-31T16:08:48.796358+00:00 | 2024-07-31T16:08:48.796358+00:00 |
| 9155f403-c407-494c-90d8-8cdb77ae5e7f | Fator VII - pesquisa e/ou dosagem | 40304680 | 1 | 2024-07-31T16:08:48.797200+00:00 | 2024-07-31T16:08:48.797200+00:00 |
| 96e174e2-3a51-40d8-8738-2a3e2ecc5d8e | Fator XIII, dosagem, teste funcional | 40304698 | 1 | 2024-07-31T16:08:48.797998+00:00 | 2024-07-31T16:08:48.797998+00:00 |
| 0e91d8a5-bb3e-400f-ab69-29cb87ec4e1d | Imunofenotipagem para doença residual mínima (*) | 40304701 | 1 | 2024-07-31T16:08:48.798794+00:00 | 2024-07-31T16:08:48.798794+00:00 |
| 4445760b-4d69-4a2f-a97c-4cc02d267639 | Imunofenotipagem para hemoglobinúria paroxistica noturna (*) | 40304710 | 1 | 2024-07-31T16:08:48.799697+00:00 | 2024-07-31T16:08:48.799697+00:00 |
| 9f105e5f-70d8-4b2f-863d-b24636aa1199 | Imunofenotipagem para leucemias agudas ou sindrome mielodisplásica (*) | 40304728 | 1 | 2024-07-31T16:08:48.800541+00:00 | 2024-07-31T16:08:48.800541+00:00 |
| 4e8b83cc-88a0-4022-99cc-aaec81f9d92a | Imunofenotipagem para linfoma não hodgkin / sindrome linfoproliferativa crônica (*) | 40304736 | 1 | 2024-07-31T16:08:48.801379+00:00 | 2024-07-31T16:08:48.801379+00:00 |
| 7f9fa8a8-6184-4709-a8a2-e773f5faa716 | Imunofenotipagem para perfil imune (*) | 40304744 | 1 | 2024-07-31T16:08:48.802337+00:00 | 2024-07-31T16:08:48.802337+00:00 |
| c6a8a09b-c355-4e12-847d-29043c159a60 | Fator IX, dosagem do inibidor | 40304752 | 1 | 2024-07-31T16:08:48.803126+00:00 | 2024-07-31T16:08:48.803126+00:00 |
| 0884d105-6183-49a5-8d9e-9fe7fe16daf2 | Inibidor dos fatores da hemostasia, triagem | 40304760 | 1 | 2024-07-31T16:08:48.804491+00:00 | 2024-07-31T16:08:48.804491+00:00 |
| b19b3978-41cd-4291-a960-02423d2cadba | Produtos de degradação da fibrina, quantitativo - pesquisa e/ou dosagem | 40304779 | 1 | 2024-07-31T16:08:48.805940+00:00 | 2024-07-31T16:08:48.805940+00:00 |